Dennis Podlesak

Director, AVANIR PHARMACEUTICALS, INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 4, 2026Granted 48,000 shares of Syndax Pharmaceuticals Inc²
Aug 18, 2025Sold 19,200 shares at $15.84 of Syndax Pharmaceuticals Inc³
Aug 18, 2025Exercised options 19,200 shares at $7.20 of Syndax Pharmaceuticals Inc³
Aug 15, 2025Sold 19,200 shares at $15.54 of Syndax Pharmaceuticals Inc³
Aug 15, 2025Exercised options 19,200 shares at $7.20 of Syndax Pharmaceuticals Inc³
Aug 14, 2025Sold 19,200 shares at $14.19 of Syndax Pharmaceuticals Inc³
Aug 14, 2025Exercised options 19,200 shares at $7.20 of Syndax Pharmaceuticals Inc³
Feb 5, 2025Granted 50,000 shares of Syndax Pharmaceuticals Inc⁴
Feb 7, 2024Granted 34,000 shares of Syndax Pharmaceuticals Inc⁵
Feb 2, 2023Granted 32,000 shares of Syndax Pharmaceuticals Inc⁶
Sep 16, 2022Sold 6,556 shares at $23.43 of Syndax Pharmaceuticals Inc⁷
Sep 16, 2022Exercised options 6,556 shares at $6.35 of Syndax Pharmaceuticals Inc⁷
Sep 16, 2022Sold 5,419 shares at $23.43 of Syndax Pharmaceuticals Inc⁷
Sep 16, 2022Exercised options 5,419 shares at $6.32 of Syndax Pharmaceuticals Inc⁷
Sep 15, 2022Sold 66,840 shares at $24.20 of Syndax Pharmaceuticals Inc⁷
Sep 15, 2022Exercised options 66,840 shares at $6.32 of Syndax Pharmaceuticals Inc⁷
Feb 2, 2022Granted 32,000 shares of Syndax Pharmaceuticals Inc⁸
Oct 5, 2021Other 463 shares of Syndax Pharmaceuticals Inc⁹

The numbers on this page point here. Each one links to the record it came from.